The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy
Abstract
OBJECTIVE: Graves' ophthalmopathy (GO) and Graves' hyperthyroidism are closely associated diseases and thought to be caused by the same autoimmune process. An obvious explanation for this would be the presence of autoantibodies reacting with an autoantigen present in the orbit and the thyroid gland. The TSH‐Receptor (TSH‐R) antibodies are a likely candidate, because they cause Graves' hyperthyroidism and the TSH‐R appears to be present also in orbital tissues. If TSH‐R antibodies are responsible for the ophthalmopathy one would expect their titres to correlate with clinical characteristics of the eye disease. The aim of the present study is to see whether TSH‐R antibodies are related to the activity and severity of the thyroid‐associated ophthalmopathy. DESIGN AND PATIENTS: TSH‐R antibody levels were measured as TBII (TRAK assay), and TSI (cAMP response of a TSH‐R transfected cell line) in serum of 63 patients with untreated moderately severe GO, accompanying Graves' thyroid disease; all patients had been euthyroid for > 2 months. RESULTS: TBII and TSI titres were strongly related to each other. TBII or TSI titres did not correlate with thyroidal or orbital disease duration, nor with TPO antibody levels. In contrast, we found a striking and highly significant correlation between the Clinical Activity Score (CAS) of the eye disease, and both TBII (r = 0.54; P < 0.0001) and TSI (r = 0.50; P < 0.0001). In addition, a weaker but significant relation was found between proptosis (in mm) and TBII (r = 0.36; P = 0.004) and TSI (r = 0.49; P = 0.0001). No correlation was found with eye muscle motility. CONCLUSION: TSH‐R antibody levels correlate directly with clinical features of Graves' ophthalmopathy. The results support the hypothesis of a pathogenetic role of TSH‐R antibodies and the TSH‐R in the orbit of Graves' ophthalmopathy patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy
Mourits, M. P., Prummel, M. F., Wiersinga, W. M., & Koornneef, L. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2331047.x · Cited by 1,001
Self-citationPrednisone and Cyclosporine in the Treatment of Severe Graves' Ophthalmopathy
Prummel, M. F., Mourits, M. P., Berghout, A., Krenning, E. P., van der Gaag, R., Koornneef, L., & Wiersinga, W. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911163212002 · Cited by 359
Self-citationExpression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue
Feliciello, A., Ciullo, I., Fenzi, G. F., Bonavolontà, G., Porcellini, A., & Avvedimento, E. V. (1993) · The Lancet · doi:10.1016/0140-6736(93)91475-2 · Cited by 288
RUNDLE, F. F., & Wilson, C. W. (1945) · PubMed · Cited by 217
Endocrine Ophthalmopathy: Current Ideas Concerning Etiology, Pathogenesis, and Treatment
JACOBSON, D. H., & GORMAN, C. A. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-2-200 · Cited by 211
Changes in Thyroid-Stimulating Immunoglobulins during Antithyroid Therapy*
Fenzi, G., Hashizume, K., Roudebush, C. P., & DeGroot, L. J. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-48-4-572 · Cited by 141
Thyrotropin Receptor Transcripts in Human Adipose Tissue
Crisp, M., Lane, C., Halliwell, M., Wynford‐Thomas, D., & Ludgate, M. E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.2003 · Cited by 134
MORRIS, J. C., HAY, I. D., NELSON, R. E., & Jiang, N. (1988) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65533-5 · Cited by 97
Lipman, L. M., Green, D. E., Snyder, N. J., Nelson, J. C., & Solomon, D. H. (1967) · The American Journal of Medicine · doi:10.1016/0002-9343(67)90175-1 · Cited by 95
Paschke, R., Vassart, G., & Ludgate, M. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02681.x · Cited by 87
Cited by
Bahn, R. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0905750 · Cited by 1,552
Current Perspective on the Pathogenesis of Graves’ Disease and Ophthalmopathy
Prabhakar, B. S., Bahn, R. S., & Smith, T. J. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0020 · Cited by 489
Eckstein, A. K., Plicht, M., Lax, H., Neuhäuser, M., Mann, K., Lederbogen, S., Heckmann, C., Esser, J., & Morgenthaler, N. G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2813 · Cited by 477
Laurberg, P., Wallin, G., Tallstedt, L., Abraham-Nordling, M., Lundell, G., & Tørring, O. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0450 · Cited by 428
Tsui, S., Naik, V., Hoa, N., Hwang, C. J., Afifiyan, N. F., Sinha Hikim, A., Gianoukakis, A. G., Douglas, R. S., & Smith, T. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.4397 · Cited by 372
Metadata
- Authors
- Gerding, M. N., van der Meer, J. W. C., Broenink, M., Bakker, O., Wiersinga, W. M., & Prummel, M. F.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2000-03
- Volume
- 52
- Issue
- 3
- Pages
- 267-271
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W1856370030
- Cited by
- 325
- References
- 14
- FWCI
- 6.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. https://app.cochat.ai/papers/10.1046/j.1365-2265.2000.00959.x
- The paper
- Gerding, M. N., van der Meer, J. W. C., Broenink, M., Bakker, O., Wiersinga, W. M., & Prummel, M. F. (2000). Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.2000.00959.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.